Plasmodium falciparum Genetic Diversity and Resistance Genotype Profile in Infected Placental Samples Collected After Delivery in Ouagadougou

References

• World Health Organisation. World malaria report 2021; 2021.
   Google Scholar
• Geiger C, Compoaré G, Coulibaly B, et al. Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulfadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina Faso. Trop Med Int Health. 2014;19(6):690–697. doi:10.1111/tmi.12305
   PubMed Web of Science ®Google Scholar
• Sondo P, Bihoun B, Kabore B, et al. Polymorphisme de Plasmodium falciparum et mutations des gènes de résistances Pfcrt et Pfmdr1 dans la zone de Nanoro, Burkina Faso [Polymorphisms in Plasmodium falciparum parasites and mutations in the resistance genes Pfcrt and Pfmdr1 in Nanoro area, Burkina Faso]. Pan Afr Med J. 2021;39(118). doi:10.11604/pamj.2021.39.118.26959
   PubMedGoogle Scholar
• Somé AF, Bazié T, Zongo I, et al. Plasmodium falciparum msp1 and msp2 genetic diversity allele frequencies in parasites isolates from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso. Parasit Vectors. 2018;11:323. doi:10.1186/s13071-2895
   PubMed Web of Science ®Google Scholar
• Cissé M, Awandare GA, Somé FA, Hayette MP, Guiguemdé RT. High concordance of Pfdhfr and Pfdhps genotypes between matched peripheral and placental isolates of delivered women in Bobo-Dioulasso, Burkina Faso. Ann Parasitol. 2017;63(2):111–116. PMID: 28802281. doi:10.17420/ap6302.93
   PubMedGoogle Scholar
• Amimo F, Lambert B, Magit A, Sacarlal J, Hashizume M, Shibuya K. Plasmodium falciparum resistance to Sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends. BMJ Global Health. 2020;e003217. doi:10.1136/bmjgh-2020-003217
   PubMed Web of Science ®Google Scholar
• Haffsatou S, Zida A, Zongo C, et al. Prevalence of placental infection with Plasmodium falciparum detected by a polymerase chain reaction and associated risk factors in women after delivered in Ouagadougou (Burkina Faso). Int J Adv Res. 2021;9(9):132–141. doi:10.21474/IJAR01/13386
   Google Scholar
• Snounou G, Viriyakosol S, Zhu XP, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61(2):315–320. PMID: 8264734. doi:10.1016/0166-6851(93)90077-b
   PubMed Web of Science ®Google Scholar
• Nébié I. Influence à long terme des rideaux imprégnés d’insecticide sur l’immunité anti-palustre chez des enfants vivant en zone rurale au Burkina Faso [Long-term influence of insecticide-impregnated curtains on malaria immunity in children living in rural areas in Burkina Faso] [dissertation]. Burkina Faso: Université de Ouagadougou; 2002.
   Google Scholar
• Abdel Hamid MM, Mohammed SB, El hassan IM. Diversité génétique des isolats de terrain de Plasmodium falciparum au Soudan central déduite par génotypage PCR desprotéines de surface de mérozoïte 1 et 2 [Genetic diversity of Plasmodium falciparum field isolates in central Sudan inferred by PCR genotyping of Merozoite Surface Protein 1 and 2]. N Am J Med Sci. 2013;5:95–101.
   PubMedGoogle Scholar
• Soulama I, Nébié I, Ouédraogo A, et al. Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso. Malar J. 2009;8:135–142. doi:10.1186/1475-2875-8-135
   PubMedGoogle Scholar
• Issifou S, Djikou S, Sanni A, Lekoulou F, Ntoumi F. No influence of season of the transmission nor age of patients on the complexity and genetic diversity of Plasmodium falciparum infection in Cotonou, Benin. Bull Soc Pathol Exot. 2001;94(2 Pt 2):195.
   PubMedGoogle Scholar
• Yavo W, Konaté A, Mawili-Mboumba DP, et al. Genetic polymorphism of msp1 and msp2 in Plasmodium falciparum Isolates from Côte d’Ivoire versus Gabon. J Parasitol Res. 2016;7. doi:10.1155/2016/3074803
   Google Scholar
• Badoum SE, Bougouma E, Sombie S, et al. Relationship between human genetic factors and Plasmodium falciparum genetic diversity of msp1, msp2 and glurp in a malaria endemic area of Burkina Faso. Biomed Genet Genomics. 2019;4(2). doi:10.15761/BGG.1000144
   Google Scholar
• Hounto AO, Gazard DK, Ndam N, et al. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from children in South of Benin. Parasite. 2013;20:37. doi:10.1051/parasite/2013039
   PubMedGoogle Scholar
• Al-Yaman F, Genton B, Reeder JC, Anders RF, Smith T, Alpers MP. Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study. Trans R Soc Trop Med Hyg. 1997;91(5):602. doi:10.1016/S0035-9203(97)90046-8
   PubMed Web of Science ®Google Scholar
• Mercereau-Puijalon O, Ménard D. Plasmodium vivax and the Duffy antigen: a paradigm revisited. Transfus Clin Biol. 2010;17(3):176–183. doi:10.1016/j.tracli.2010.06.005
   PubMed Web of Science ®Google Scholar
• Gunawardena S, Karunaweera ND. Advances in genetics and genomics: use and limitations in achieving malaria elimination goals. Pathog Glob Health. 2015;109(3):123–141. doi:10.1179/2047773215Y.0000000015
   PubMed Web of Science ®Google Scholar
• Mahamar A, Sumner KM, Levitt B, et al. Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali. Malar J. 2022;21:39. doi:10.1186/s12936-022-04059-z
   PubMed Web of Science ®Google Scholar
• Coulibaly SO, Kayentao K, Taylor S, et al. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study. Malar J. 2014;13:41. doi:10.4269/ajtmh.2011.10-0507
   PubMed Web of Science ®Google Scholar
• Chauvin P, Sandie M, Iriart X, et al. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles. J Antimicrob Chemother. 2015;70(5). doi:10.1093/jac/dkv160
   PubMedGoogle Scholar
• Tahita MC, Tinto H, Erhart A, et al. Prevalence of the dhfr and dhps mutations among pregnant women in rural Burkina Faso five years after the introduction of intermittent preventive treatment with sulfadoxine-pyrimethamine. PLoS One. 2015;10(9):e0137440. doi:10.1371/journal.pone.0137440
   PubMed Web of Science ®Google Scholar
• Tinto H, Ouédraogo JB, Zongo I, et al. Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. Am J Trop Med Hyg. 2007;76(4):608. doi:10.4269/ajtmh.2007.76.608
   PubMed Web of Science ®Google Scholar
• Nikiema S. Etude de l’influence de la chimioprévention du paludisme saisonnier sur la prévalence de l’infection palustre, la diversité génétique du parasite et la prévalence des marqueurs de résistance de Plasmodium falciparum chez les enfants vivant en zone rurale au Burkina Faso [Study of the influence of seasonal malaria chemoprevention on the prevalence of malaria infection, parasite genetic diversity and the prevalence of Plasmodium falciparum resistance markers in children living in rural areas of Burkina Faso]. [Dissertation] [Thèse PhD]. Université Joseph KI-ZERBO Ouagadougou Burkina Faso; 2022.
   Google Scholar
• Baba E, Hamade P, Kivumbi H, et al. Effectiveness of seasonal malaria chemoprevention at scale in west and Central Africa: an observational study. Lancet. 2020;396:1829–1840. doi:10.1016/S0140-6736(20)32227-3
   PubMed Web of Science ®Google Scholar
• Iwalokun BA, Iwalokun SO, Adebodun V, Balogun M. Carriage of mutant dihydrofolate reductase and dihydropteroate synthase genes among plasmodium falciparum isolates recovered from pregnant women with asymptomatic infection in Lagos, Nigeria. Med Princ Pract. 2015;24(5):436. doi:10.1159/000430987
   PubMed Web of Science ®Google Scholar
• Bouyou-Akotet MK, Mawili-Mboumba DP, Tchantchou TD, Kombila M. High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women when introducing intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon. J Antimicrob Chemother. 2010;65(3):438‑41. doi:10.1093/jac/dkp467
   PubMed Web of Science ®Google Scholar
• Talisuna AO, Bloland P, Alessandro D, Alessandro UD. History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev. 2004;17(1):235‑54. doi:10.1128/CMR.17.1.235-254.2004
   PubMed Web of Science ®Google Scholar
• Hastings I. Modelling parasite drug resistance: lessons for management and control strategies. Trop Med Int Health. 2001;6:883–890. doi:10.1046/j.1365-3156.2001.00800.x
   PubMed Web of Science ®Google Scholar
• Hastings I, D’Alessandro U. Modelling a predictable disaster: the rise and spread of drug-resistant malaria. Parasitol Today. 2000;16:340. doi:10.1016/S0169-4758(00)01707-5
   PubMedGoogle Scholar
• Cisse M, Awandare GA, Soulama A, Tinto H, Hayette MP, Guiguemdé RT. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso. Malar J. 2017;16(1):38. PMID: 28114990; PMCID: PMC5259838. doi:10.1186/s12936-017-1695-1
   PubMedGoogle Scholar